Regeneron Pharmaceuticals Inc (REGN)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | 14.234 | 15.231 | 23.849 | 15.944 | 21.979 | 37.914 | 15.877 | 12.693 |
| Return on Equity (%) | 22.101 | 22.628 | 32.808 | 21.321 | 31.772 | 54.207 | 20.942 | 16.258 |
| Return on Invested Capital (%) | 29.838 | 30.494 | 42.064 | 26.677 | 38.453 | 69.274 | 28.802 | 20.938 |
| Operating Margin (%) | 27.508 | 35.823 | 38.471 | 31.275 | 45.513 | 58.383 | 40.403 | 32.57 |
| Net Profit Margin (%) | 18.425 | 20.41 | 36.425 | 26.907 | 41.346 | 50.245 | 35.64 | 30.141 |
| Book Value Per Share | 20.756 | 27.292 | 38.352 | 49.752 | 50.984 | 85.431 | 98.167 | 113.215 |
| Earnings Per Share | 4.178 | 5.324 | 10.705 | 9.492 | 16.246 | 36.757 | 19.582 | 17.951 |
| Cash Per Share | 2.497 | 3.61 | 6.428 | 7.258 | 10.144 | 13.135 | 14.019 | 12.396 |
| Working Capital Per Share | 9.044 | 14.212 | 21.918 | 25.09 | 32.748 | 45.893 | 57.517 | 72.901 |
| Operating Profit Per Share | 21.764 | 24.952 | 28.12 | 32.689 | 36.478 | 63.547 | 49.849 | 53.235 |
| EBIT Per Share | 6.204 | 9.233 | 11.183 | 10.898 | 17.62 | 42.449 | 21.931 | 19.067 |
| EBITDA Per Share | 6.204 | 9.233 | 11.183 | 10.898 | 17.62 | 42.449 | 21.931 | 19.067 |
| Free Cash Flow Per Share | 6.077 | 5.903 | 11.752 | 10.499 | 18.021 | 37.989 | 25.339 | 20.246 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 104.1M | 109.48M | 111.09M | 108.43M | 105.1M | 106.85M | 107.8M | N/A |
| Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 107M | 107.8M | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | 27.703 | N/A | N/A | N/A | 22.792 | N/A |
| Net Profit Margin (%) | N/A | N/A | 25.863 | N/A | N/A | N/A | 22.957 | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 125.27B |
| Price to Earnings Ratio | 31.83 |
| Price to Sales Ratio | 9.59 |
| Price to Cash Ratio | 46.09 |
| Price to Book Ratio | 4.84 |
| Dividend Yield | - |
| Shares Outstanding | 110.23M |
| Average Volume (1 week) | 427.31k |
| Average Volume (1 Month) | 461.78k |
| 52 Week Change | 74.51% |
| 52 Week High | 1,211.1999 |
| 52 Week Low | 538.01 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
